Allianz Asset Management’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-7,400
| Closed | -$276K | – | 1725 |
|
|
2023
Q1 | $276K | Buy |
+7,400
| New | +$276K | ﹤0.01% | 1517 |
|
|
2022
Q3 | – | Sell |
-96,118
| Closed | -$4.98M | – | 1590 |
|
|
2022
Q2 | $4.98M | Buy |
96,118
+23,266
| +32% | +$1.2M | ﹤0.01% | 1043 |
|
|
2022
Q1 | $5.3M | Sell |
72,852
-9,888
| -12% | -$719K | ﹤0.01% | 1075 |
|
|
2021
Q4 | $9.8M | Buy |
82,740
+5,245
| +7% | +$621K | 0.01% | 931 |
|
|
2021
Q3 | $10.4M | Buy |
77,495
+27,354
| +55% | +$3.67M | 0.01% | 895 |
|
|
2021
Q2 | $8.12M | Buy |
50,141
+11,972
| +31% | +$1.94M | 0.01% | 879 |
|
|
2021
Q1 | $3.06M | Sell |
38,169
-3,520
| -8% | -$282K | ﹤0.01% | 1139 |
|
|
2020
Q4 | $2.27M | Buy |
+41,689
| New | +$2.27M | ﹤0.01% | 1261 |
|
|
2020
Q2 | – | Sell |
-68,595
| Closed | -$839K | – | 1973 |
|
|
2020
Q1 | $839K | Sell |
68,595
-34,588
| -34% | -$423K | ﹤0.01% | 1496 |
|
|
2019
Q4 | $1.51M | Buy |
103,183
+11,794
| +13% | +$173K | ﹤0.01% | 1565 |
|
|
2019
Q3 | $1.22M | Sell |
91,389
-92,314
| -50% | -$1.23M | ﹤0.01% | 1617 |
|
|
2019
Q2 | $3.01M | Buy |
183,703
+12,778
| +7% | +$209K | ﹤0.01% | 1418 |
|
|
2019
Q1 | $2.92M | Buy |
170,925
+42,533
| +33% | +$726K | ﹤0.01% | 1434 |
|
|
2018
Q4 | $1.75M | Buy |
128,392
+6,738
| +6% | +$92K | ﹤0.01% | 1509 |
|
|
2018
Q3 | $3.48M | Buy |
121,654
+41,765
| +52% | +$1.2M | ﹤0.01% | 1401 |
|
|
2018
Q2 | $2.19M | Buy |
+79,889
| New | +$2.19M | ﹤0.01% | 1494 |
|